Literature DB >> 3050282

Immunohistological characterization of human monoclonal antibody against lung cancer.

T Yano1, K Yasumoto, A Nagashima, H Murakami, S Hashizume, K Nomoto.   

Abstract

Using immunoperoxidase staining method, a human monoclonal antibody (MAb), termed HB4C5, which was generated by fusion of NAT-30 cells with regional lymph node lymphocytes from a lung cancer patient, was examined for tumor specificity. The determinant recognized by HB4C5 MAb was well preserved in usual formalin-fixed paraffin-embedded tissue sections. Experiments with four major histological types of the lung cancer showed that HB4C5 MAb reacted with adenocarcinoma (19/27), squamous cell carcinoma (2/15), and large cell carcinoma (4/6), but not with small cell carcinoma (0/7). The immunoreaction was seen in the cytoplasm. In addition, this MAb also reacted with some gastric and colon adenocarcinomas. Further study on normal lung and nonpulmonary tissues revealed that HB4C5 MAb bound only type II pneumocytes and proximal tubules of normal kidney.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3050282     DOI: 10.1002/jso.2930390208

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  11 in total

1.  Stimulation of proliferation and immunoglobulin production of human-human hybridoma by various types of caseins and their protease digests.

Authors:  K Yamada; I Ikeda; H Nakajima; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1991-03       Impact factor: 2.058

2.  Building high affinity human antibodies by altering the glycosylation on the light chain variable region in N-acetylglucosamine-supplemented hybridoma cultures.

Authors:  H Tachibana; J Y Kim; S Shirahata
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

3.  Availability of oncogene activated production system for mass production of light chain of human antibody in CHO cells.

Authors:  T Miura; Y Katakura; P Seto; Y Zhang; K Teruya; E Nishimura; M Kato; S Hashizume; S Shirahata
Journal:  Cytotechnology       Date:  2001-01       Impact factor: 2.058

4.  Modified antigen-binding of human antibodies with glycosylation variations of the light chains produced in sugar-limited human hybridoma cultures.

Authors:  H Tachibana; K Jiyoun; K Taniguchi; Y Ushio; K Teruya; K Osada; Y Inoue; S Shirahata; H Murakami
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-03       Impact factor: 2.416

5.  Enhanced production of human monoclonal antibodies by the use of fructose in serum-free hybridoma culture media.

Authors:  K Mochizuki; S Sato; M Kato; S Hashizume
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

6.  Epitope in cytochrome c from Candida krusei cross-reacts lung cancer-specific human monoclonal antibody HB4C5.

Authors:  S Kawamoto; S Hashizume; Y Katakura; H Tachibana; S Shirahata; H Murakami
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-06       Impact factor: 2.416

7.  Improvement of antigen binding ability of human antibodies by light chain shifting.

Authors:  T Siripen; H Tachibana; Y Katakura; S Shirahata
Journal:  Cytotechnology       Date:  1997-11       Impact factor: 2.058

8.  Stimulation of monoclonal antibody production by human-human hybridoma cells with an elevated concentration of potassium or sodium phosphate in serum-free medium.

Authors:  S Sato; H Murakami; T Sugahara; T Ikegami; K Yamada; H Omura; S Hashizume
Journal:  Cytotechnology       Date:  1989-02       Impact factor: 2.058

9.  Molecular cloning of yeast cytochrome c-like polypeptide expressed in human lung carcinoma: an antigen recognizable by lung cancer-specific human monoclonal antibody.

Authors:  S Kawamoto; S Hashizume; Y Katakura; H Tachibana; H Murakami
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-10       Impact factor: 2.416

10.  Stimulation of proliferation and immunoglobulin M production by lactoferrin in human-human and mouse-mouse hybridomas cultures in serum-free conditions.

Authors:  K Yamada; I Ikeda; T Sugahara; S Hashizume; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.